Teva Pharmaceutical Industries Ltd (TEVA.N)
|Market Cap (Mil.):||$51,850.31|
|Shares Outstanding (Mil.):||951.29|
TEL AVIV, July 14 - Teva Pharmaceutical Industries board is to appoint vice-chairman Amir Elstein as its new chairman, activist shareholder Benny Landa said on Monday.
* Six companies get combined penalty of 428 million euros
BRUSSELS, July 9 - European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others 427.7 million euros ($583.40 million) on Wednesday for blocking cheaper generic medicine.
TEL AVIV, July 3 - Teva Pharmaceutical Industries has filed a so-called citizen petition with the U.S. Food and Drug Administration (FDA), aiming to delay cheap generic competition to Copaxone, its top-selling treatment for multiple sclerosis (MS).
(Adds details of drugs to be divested, share price, other pharma deals)
BRUSSELS, June 19 - EU antitrust regulators are set to fine French drugmaker Servier, Israel's Teva and several of their peers next month for blocking cheaper generic medicine, two people with knowledge of the matter said on Thursday.
* Teva shares up 0.7 percent in New York (Adds details, background, share reaction)
TEL AVIV, June 18 - Phillip Frost, chairman of the world's biggest generic drugmaker Teva Pharmaceutical Industries , said on Wednesday he will step down by the end of this year.
TEL AVIV - Teva Pharmaceutical Industries is launching three new products in 2014 with combined estimated peak sales of $1 billion, the chief executive of the world's biggest generic drugmaker said on Tuesday.
TEL AVIV, May 20 - Teva Pharmaceutical Industries is launching three new products in 2014 with combined estimated peak sales of $1 billion, the chief executive of the world's biggest generic drugmaker said on Tuesday.